Download

Full Text

See more details

X (1)

Mendeley (35)

13

CITATIONS

13 Total citations

3 Recent citations

2.95 Field Citation Ratio

0.55 Relative Citation Ratio

publications

0

supporting

0

mentioning

0

contrasting

0

Smart Citations

0

0

0

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

• Irimia P, Palma JA, Fernandez-Torron R, et al. Refractory migraine in a headache clinic population. BMC Neurol 2011; 11: 94-94.
• Whyte CA, Tepper SJ,. Adverse effects of medications commonly used in the treatment of migraine. Expert Rev Neurother 2009; 9: 1379-1391.
• Edvinsson L, Villalón CM, MaassenVanDenBrink A,. Basic mechanisms of migraine and its acute treatment. Pharmacol Ther 2012; 136: 319-333.
• Schueler M, Neuhuber WL, De Col R, et al. Innervation of rat and human dura mater and pericranial tissues in the parieto-temporal region by meningeal afferents. Headache 2014; 54: 996-1009.
• Schueler M, Messlinger K, Dux M, et al. Extracranial projections of meningeal afferents and their impact on meningeal nociception and headache. Pain 2013; 154: 1622-1631.
• Knight G,. Surgical treatment of migraine. Proc R Soc Med 1962; 55: 172-176.
• Matharu MS, Boes CJ, Goadsby PJ,. Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs 2003; 63: 1637-1677.
• Anthony M, The role of the occipital nerve in unilateral headache. In: Rose FC, (ed). Current Problems in Neurology: 4. Advances in Headache Research, London: John Libbey, 1987, pp. 257-262.
• Kerr FWL,. A mechanism to account for frontal headache in cases of posterior fossa tumour. J Neurosurg 1961; 18: 605-609.
• Ashkenazi A, Matro R, Shaw JW, et al. Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study. J Neurol Neurosurg Psychiatry 2008; 79: 415-417.
• Dilli E, Halker R, Vargas B, et al. Occipital nerve block for the short-term preventive treatment of migraine: a randomized, double-blinded, placebo-controlled study. Cephalalgia 2015; 35: 959-968.
• Kashipazha D, Nakhostin-Mortazavi A, Mohammadianinejad SE, et al. Preventive effect of greater occipital nerve block on severity and frequency of migraine headache. Glob J Health Sci 2014; 6: 209-213.
• Inan LE, Inan N, Karadas O, et al. Greater occipital nerve for the treatment of chronic migraine: a randomized, multicenter, double-blind, parallel and placebo-controlled study. Acta Neurol Scand 2015. Epub ahead of print. doi: 10.1111/ane.12393.
• Palamar D, Uluduz D, Saip S, et al. Ultrasound-guided greater occipital nerve block: an efficient technique in chronic refractory migraine without aura? Pain Physician 2015; 18: 153-162.
• Gelfand AA, Reider AC, Goadsby PJ,. Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders. Pediatr Neurol 2014; 50: 135-139.
• Afridi SK, Shields KG, Bhola R, et al. Greater occipital nerve injection in primary headache syndromes-prolonged effects from a single injection. Pain 2006; 122: 126-129.
• Weibelt S, Andress-Rothrock D, King W, et al. Suboccipital nerve blocks for suppression of chronic migraine: safety, efficacy, and predictors of outcome. Headache 2010; 50: 1041-1044.
• Tobin JA, Flitman SS,. Occipital nerve blocks: effect of symptomatic medication: overuse and headache type on failure rate. Headache 2009; 49: 1479-1485.
• Kinfe T, Schuss P, Vatter H,. Occipital nerve block prior to occipital nerve stimulation for refractory chronic migraine and chronic cluster headache: myth or prediction? Cephalalgia 2015; 35: 359-362.
• Bovim G, Sand T,. Cervicogenic headache, migraine without aura and tension-type headache. Diagnostic blockade of greater occipital and supra-orbital nerves. Pain 1992; 51: 43-48.
• Ashkenazi A, Young WB,. The effects of greater occipital nerve block and trigger point injection on brush allodynia and pain in migraine. Headache 2005; 45: 350-354.
• Young W, Cook B, Malik S, et al. The first 5 minutes after greater occipital nerve block. Headache 2008; 48: 1126-1128.
• Baron EP, Tepper SJ, Mays M, et al. Acute treatment of basilar-type migraine with greater occipital nerve blockade. Headache 2010; 50: 1057-1059.
• Caputi CA, Firetto V,. Therapeutic blockade of greater occipital and supraorbital nerves in migraine patients. Headache 1997; 37: 174-179.
• Ilhan Alp S, Alp R,. Supraorbital and infraorbital nerve blockade in migraine patients: results of 6-month clinical follow-up. Eur Rev Med Pharmacol Sci 2013; 17: 1778-1781.
• Cady RK, Saper J, Dexter K, et al. Long-term efficacy of a double-blind, placebo-controlled, randomized study for repetitive sphenopalatine blockade with bupivacaine vs saline with the Tx360® device for treatment of chronic migraine. Headache 2015; 55: 529-542.
• Leroux E, Ducros A,. Occipital injections for trigemino-autonomic cephalalgias: evidence and uncertainties. Curr Pain Headache Rep 2013; 17: 325-325.
• Anthony M,. Headache and the greater occipital nerve. Clin Neurol Neurosurg 1992; 94: 297-301.
• Ambrosini A, Vandenheede M, Rossi P, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain 2005; 118: 92-96.
• Busch V, Jakob W, Juergens T, et al. Occipital nerve blockade in chronic cluster headache patients and functional connectivity between trigeminal and occipital nerves. Cephalalgia 2007; 27: 1206-1214.
• Leroux E, Valade D, Taifas I, et al. Suboccipital steroid injections for transitional treatment of patients with more than 2 cluster headache attacks per day: a randomized, double-blind, placebo-controlled trial. Lancet Neurol 2011; 10: 891-897.
• Robbins MS,. Peripheral nerve blocks, steroid injections and their niche in headache medicine. Cephalalgia 2015; 25: 850-852.
• Lambru G, Lagrata S, Matharu MS,. Cutaneous atrophy and alopecia after greater occipital nerve injection using triamcinolone. Headache 2012; 52: 1596-1599.
• Melzack R, Wall PD,. Pain mechanisms: a new theory. Science 1965; 150: 971-979.
• DeSantana JM, Da Silva LF, De Resende MA, et al. Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats. Neuroscience 2009; 163: 1233-1241.
• Bartsch T, Goadsby PJ,. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain 2003; 126: 1801-1813.
• Serra G, Marchioretto F,. Occipital nerve stimulation for chronic migraine: a randomized trial. Pain Physician 2012; 15: 245-253.
• Saper JR, Dodick DW, Silberstein SD, et al. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia 2011; 31: 271-285.
• Lipton R, Goadsby P, Cady R, et al. PRISM study: occipital nerve stimulation for treatment-refractory migraine. Cephalalgia 2009; 29 (Suppl. 1): 30-30.
• Silberstein S, Dodick D, Saper J, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia 2012; 32: 1165-1179.
• Dodick DW, Silberstein SD, Reed KL, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia 2015; 35: 344-358.
• Slotty PJ, Bara G, Kowatz L, et al. Occipital nerve stimulation for chronic migraine: a randomized trial on subthreshold stimulation. Cephalalgia 2015; 35: 73-78.
• Chen YF, Bramley G, Unwin G, et al. Occipital nerve stimulation for chronic migraine-a systematic review and meta-analysis. PLoS ONE 2015; 10 (3): e0116786-e0116786.
• Reed KL, Black SB, Banta CJ 2nd, et al. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalalgia 2010; 30: 260-271.
• Reed KL, Will KR, Chapman J, et al. Combined occipital and supraorbital neurostimulation for chronic migraine headaches: an extended case series. Cephalalgia 2011; 31 (Suppl. 1): 98-98.
• Burns B,. 'Dual' occipital and supraorbital nerve stimulation for primary headache. Cephalalgia 2010; 30: 257-259.
• Reed KL, Will KR, Conidi F, et al. Concordant occipital and supraorbital neurostimulation therapy for hemiplegic migraine; initial experience; a case series. Neuromodulation 2015; 18: 297-303.
• Kovacs S, Peeters R, De Ridder D, et al. Central effects of occipital nerve electrical stimulation studied by functional magnetic resonance imaging. Neuromodulation 2011; 14: 46-55.
• Burns B, Watkins L, Goadsby PJ,. Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet 2007; 369: 1099-1106.
• Magis D, Allena M, Bolla M, et al. Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol 2007; 6: 314-321.
• Fontaine D, Sol JC, Raoul S, et al. Treatment of refractory chronic cluster headache by chronic occipital nerve stimulation. Cephalalgia 2011; 31: 1101-1105.
• Strand NH, Trentman TL, Vargas BB, et al. Occipital nerve stimulation with the Bion® microstimulator for the treatment of medically refractory chronic cluster headache. Pain Physician 2011; 14: 435-440.
• Mueller OM, Gaul C, Katsarava Z, et al. Occipital nerve stimulation for the treatment of chronic cluster headache-lessons learned from 18 months experience. Cent Eur Neurosurg 2011; 72: 84-89.
• Burns B, Watkins L, Goadsby PJ,. Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients. Neurology 2009; 72: 341-345.
• Magis D, Gerardy PY, Remacle JM, et al. Sustained effectiveness of occipital nerve stimulation in drug-resistant chronic cluster headache. Headache 2011; 51: 1191-1201.
• Mueller O, Diener HC, Dammann P, et al. Occipital nerve stimulation for intractable chronic cluster headache or migraine: a critical analysis of direct treatment costs and complications. Cephalalgia 2013; 33: 1283-1291.
• Wilbrink LA, Teernstra OP, Haan J, et al. Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: rationale and protocol of a randomised trial. Cephalalgia 2013; 33: 1238-1247.
• Schwedt T, Dodick D, Hentz J, et al. Occipital nerve stimulation for chronic headache-long-term safety and efficacy. Cephalalgia 2007; 27: 153-157.
• Schwedt TJ, Dodick DW, Trentman TL, et al. Occipital nerve stimulation for chronic cluster headache and hemicrania continua: pain relief and persistence of autonomic features. Cephalalgia 2006; 26: 1025-1027.
• Mammis A, Gudesblatt M, Mogilner AY,. Peripheral neurostimulation for the treatment of refractory cluster headache, long-term follow-up: case report. Neuromodulation 2011; 14: 432-435. discussion 435.
• Vaisman J, Markley H, Ordia J, et al. The treatment of medically intractable trigeminal autonomic cephalalgia with supraorbital/supratrochlear stimulation: a retrospective case series. Neuromodulation 2012; 15: 374-380.
• Brewer AC, Trentman TL, Ivancic MG, et al. Long-term outcome in occipital nerve stimulation patients with medically intractable primary headache disorders. Neuromodulation 2013; 16: 557-562. discussion 563-564.
• Oh MY, Ortega J, Bellotte JB, et al. Peripheral nerve stimulation for the treatment of occipital neuralgia and transformed migraine using a C1-2-3 subcutaneous paddle style electrode: a technical report. Neuromodulation 2004; 7: 103-112.
• Paemeleire K, Van Buyten JP, Van Buynder M, et al. Phenotype of patients responsive to occipital nerve stimulation for refractory head pain. Cephalalgia 2010; 30: 662-673.
• Magis D, Bruno MA, Fumal A, et al. Central modulation in cluster headache patients treated with occipital nerve stimulation: an FDG-PET study. BMC Neurol 2011; 11: 25-25.
• Martelletti P, Jensen RH, Antal A, et al. European Headache Federation. Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain 2013; 14: 86-86.
• Guyuron B, Varghai A, Michelow BJ, et al. Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg 2000; 106: 429-434.
• Guyuron B, Tucker T, Davis J,. Surgical treatment of migraine headaches. Plast Reconstr Surg 2002; 109: 2183-2189.
• Guyuron B, Kriegler JS, Davis J, et al. Comprehensive surgical treatment of migraine headaches. Plast Reconstr Surg 2005; 115: 1-9.
• Guyuron B, Kriegler JS, Davis J, et al. Five-year outcome of surgical treatment of migraine headaches. Plast Reconstr Surg 2011; 127: 603-608.
• Guyuron B, Reed D, Kriegler JS, et al. A placebo-controlled surgical trial of the treatment of migraine headaches. Plast Reconstr Surg 2009; 124: 461-468.
• Larson K, Lee M, Davis J, et al. Factors contributing to migraine headache surgery failure and success. Plast Reconstr Surg 2011; 128: 1069-1075.
• Liu MT, Armijo BS, Guyuron B,. A comparison of outcome of surgical treatment of migraine headaches using a constellation of symptoms versus botulinum toxin type A to identify the trigger sites. Plast Reconstr Surg 2012; 129: 413-419.
• Lee M, Monson MA, Liu MT, et al. Positive botulinum toxin type a response is a prognosticator for migraine surgery success. Plast Reconstr Surg 2013; 131: 751-757.
• Chepla KJ, Oh E, Guyuron B,. Clinical outcomes following supraorbital foraminotomy for treatment of frontal migraine headache. Plast Reconstr Surg 2012; 129: 656e-662e.
• Chmielewski L, Liu MT, Guyuron B,. The role of occipital artery resection in the surgical treatment of occipital migraine headaches. Plast Reconstr Surg 2013; 131: 351e-356e.
• Dirnberger F, Becker K,. Surgical treatment of migraine headaches by corrugator muscle resection. Plast Reconstr Surg 2004; 114: 652-657.
• Poggi JT, Grizzell BE, Helmer SD,. Confirmation of surgical decompression to relieve migraine headaches. Plast Reconstr Surg 2008; 122: 115-122.
• de Ru JA, Schellekens PP, Lohuis PJ,. Corrugator supercilii transection for headache emanating from the frontal region: a clinical evaluation of ten patients. J Neural Transm 2011; 118: 1571-1574.
• D'Amico D, Leone M, Bussone G,. Side-locked unilaterality and pain localization in long-lasting headaches: migraine, tension-type headache, and cervicogenic headache. Headache 1994; 34: 526-530.
• Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629-808.
• Jackson JL, Kuriyama A, Hayashino Y,. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. JAMA 2012; 307: 1736-1745.
• Meissner K, Fassler M, Rucker G, et al. Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA Intern Med 2013; 173: 1941-1951.
• De Tommaso M, Ambrosini A, Brighina F, et al. Altered sensory processing in migraine. Nat Rev Neurol 2014; 10: 144-155.